Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.

BACKGROUND: A number of surgical series have been reported on the treatment of acromegaly and their results vary widely. The acceptable definition of remission has changed in recent years and it is known, though in a small series, that growth hormone levels of > 5 mU/l are still associated wi...

Full description

Bibliographic Details
Main Authors:	Ahmed, S, Elsheikh, M, Stratton, I, Page, R, Adams, C, Wass, J
Format:	Journal article
Language:	English
Published:	1999

Similar Items

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
by: Sheaves, R, et al.
Published: (1996)

Acromegaly: Beyond surgery.
by: Thanabalasingham, G, et al.
Published: (2013)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
by: Karavitaki, N, et al.
Published: (2008)

Investigation protocol: acromegaly and its investigation.
by: Duncan, E, et al.
Published: (1999)

New treatments for acromegaly.
by: Wass, J, et al.
Published: (1998)

Using acute hypervolaemic haemodilution as blood conservation technique in a Jehovah’s witness patient undergoing an emergency transphenoidal surgery: a Sabah experience
by: Yeap, Boon Tat, et al.
Published: (2021)

Acromegaly: Treatment with somatostatin analogs
by: Karavitaki, N, et al.
Published: (2005)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
by: Wass, J
Published: (1997)

Long-term effects of radiotherapy for acromegaly.
by: Wass, J
Published: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
by: Wass, J
Published: (2003)

Pegvisomant: a new treatment modality for acromegaly.
by: Karavitaki, N, et al.
Published: (2004)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
by: Wass, J
Published: (2003)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
by: Grossman, A, et al.
Published: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
by: Grossman, A, et al.
Published: (1986)

Acromegaly, colonic polyps and carcinoma.
by: Jenkins, P, et al.
Published: (1997)

Guidelines for acromegaly management.
by: Melmed, S, et al.
Published: (2002)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
by: Kaltsas, G, et al.
Published: (2001)

Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
by: Wass, J
Published: (1997)

The pathology of median neuropathy in acromegaly.
by: Jenkins, P, et al.
Published: (2000)

Hypercalcaemia in acromegaly is not always due to men-1
by: Zabuliene, L, et al.
Published: (2005)

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
by: Fernandez, A, et al.
Published: (2008)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Acromegaly or chronic renal failure: a diagnostic dilemma.
by: Wong, N, et al.
Published: (1997)

Criteria for cure of acromegaly: a consensus statement.
by: Giustina, A, et al.
Published: (2000)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
by: Ur, E, et al.
Published: (1992)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
by: Pereira, E, et al.
Published: (2010)

Menstrual irregularity in women with acromegaly.
by: Kaltsas, G, et al.
Published: (1999)

Uterine leiomyomata in women with acromegaly
by: Kaltsas, G, et al.
Published: (2000)

Guidelines for acromegaly management: an update.
by: Melmed, S, et al.
Published: (2009)

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
by: Karavitaki, N, et al.
Published: (2009)

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
by: Turner, H, et al.
Published: (2004)

Accounting for the placebo effect of surgery in surgical trials?
by: Beard, D, et al.
Published: (2013)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure.
by: Borley, N, et al.
Published: (2002)

Surgical specialty, surgical unit volume and mortality after oesophageal cancer surgery.
by: Leigh, Y, et al.
Published: (2009)

Cardiovascular changes in patients with acromegaly assessed by CMR.
by: Zemrak, F, et al.
Published: (2012)

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
by: Besser, G, et al.
Published: (1983)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
by: Chahal, H, et al.
Published: (2010)

Acromegaly: a unique human headache model.
by: Levy, M, et al.
Published: (2003)

Improving surgical and medical outcomes, beyond maternal mortality
by: Paterson, A, et al.
Published: (2022)